NHS Reintroduces Varenicline to Help 85,000 Smokers Quit Annually, Aiming to Prevent 9,500 Deaths

November 12, 2024
NHS Reintroduces Varenicline to Help 85,000 Smokers Quit Annually, Aiming to Prevent 9,500 Deaths
  • Varenicline, a non-nicotine pill, has been reintroduced by the NHS to assist smokers in quitting by reducing cravings and withdrawal symptoms.

  • NHS England's chief executive, Amanda Pritchard, has called Varenicline a 'game changer,' aiming to help over 85,000 people quit smoking each year and potentially prevent 9,500 smoking-related deaths over the next five years.

  • With approximately 6 million adults in the UK still smoking, smoking remains the leading cause of preventable illness and death, costing the NHS around £2.5 billion annually in related health issues.

  • The rollout of Varenicline was announced during the NHS Providers’ annual conference, highlighting the importance of this initiative in addressing public health concerns associated with smoking.

  • The NHS emphasizes a supportive, non-judgmental approach to smoking cessation, providing resources such as one-on-one appointments and group sessions to enhance the chances of quitting.

  • Health Secretary Wes Streeting noted the economic benefits of Varenicline, stating it could save the NHS money while promoting a healthier society.

  • Research shows that every £1 spent on Varenicline could save £1.65 in healthcare costs, making it a cost-effective solution for smoking cessation.

  • The medication will be available only through prescriptions from GPs, pharmacists, or stop smoking advisers, ensuring proper guidance for users.

  • Campaigners have welcomed the reintroduction of Varenicline, emphasizing the need for comprehensive support systems for smokers wishing to quit.

  • Clinical evidence suggests that Varenicline, especially when combined with behavioral support, is more effective than traditional nicotine-replacement therapies.

  • The introduction of Varenicline coincides with new tobacco legislation aimed at gradually raising the legal age for tobacco purchases and imposing stricter regulations on vaping.

  • Varenicline, previously marketed as Champix, has been reapproved as safe by the MHRA after being withdrawn in 2021 due to safety concerns, and is now available through NHS Stop Smoking Services.

Summary based on 7 sources


Get a daily email with more UK News stories

More Stories